Rona Yaeger

Based at Cornell University, Rona Yaeger focuses their scholarly efforts on colorectal cancer, lung cancer, BRAF mutations, KRAS mutations, ctDNA monitoring, targeted therapy, clinical trials, cancer evolution, bridging the gap between theory and practice in colorectal cancer. A representative example of their recent contribution is the study titled "Long-Term Results of Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy: The Randomized Phase II OPRA Trial", which offers critical insights into the dynamics of colorectal cancer and lung cancer. Additional work such as "Adagrasib in Advanced Solid Tumors Harboring a<i>KRAS</i>^<i>G12C</i>Mutation" further demonstrates their commitment to advancing knowledge in this domain.